Skip to content
To the full analysis

British American Tobacco p.l.c. stock: growth

BTI
$61.04Closing price of 12 Nov 2026MEQIRI Score 62 out of 100

British American Tobacco p.l.c. reported $33.95B in revenue for fiscal 2025, down 1% on the prior year, down 0.1% a year on average over up to five years.

Daily figure as of 13 Nov 2026

Revenue (Annual rate)
5.2%
per year from 2006 to 2025, per share 5.4%
Earnings (Annual rate)
7.7%
per year from 2006 to 2025, per share 7.3%
Free cash flow (Annual rate)
7.6%
per year from 2006 to 2025, per share 7.7%

Growth per year by period

What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.

since 2020since 2015since 2006
Revenue−0.1%7.4%5.2%
Revenue per share0.5%7.7%5.4%
Earnings3.9%6.1%7.7%
Earnings per share4.6%4.3%7.3%
Free cash flow−9.0%3.2%7.6%
Free cash flow per share−8.4%3.5%7.7%

Fiscal years at a glance

How revenue and earnings grow

  • Revenue
  • Earnings
  • Free cash flow
Figures as a table
YearRevenueEarningsFree cash flow
2006$12.94B$2.51B$1.92B
2007$13.28B$2.82B$2.36B
2008$16.07B$3.26B$3.79B
2009$18.83B$3.6B$3.47B
2010$19.73B$3.82B$4.45B
2011$20.41B$4.1B$4.4B
2012$20.14B$5.09B$4.99B
2013$20.23B$5.17B$5.12B
2014$18.52B$4.13B$4.22B
2015$16.62B$5.69B$5.62B
2016$18.73B$6.16B$5.33B
2017$25.93B$49.75B$6.04B
2018$32.47B$8B$12.64B
2019$34.3B$7.56B$11.04B
2020$34.17B$8.48B$12.29B
2021$34.05B$9.02B$12.18B
2022$36.66B$8.84B$13.08B
2023$36.17B−$19.04B$13.59B
2024$34.29B$4.07B$12.62B
2025$33.95B$10.29B$7.68B

Revenue by segment

How British American Tobacco p.l.c. makes its money and how that has shifted. Names are as the company reports them.

  • Combustibles$26.8B79%
  • Traditional Oral$1.4B4%
  • Other$5.8B17%

“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies. The company split earlier years differently. A history would not be comparable, so only 2025 is shown.

Figures as a table
2025Share 2025
Combustibles$26.78B78.9%
Traditional Oral$1.38B4.1%
Other$5.79B17%
Total revenue$33.95B100%

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = £0.7544)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Neutral, published since 7 Nov 2026 (in the score history since 31 May 2024)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy